{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:07:46Z","timestamp":1770790066687,"version":"3.50.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Research","doi-asserted-by":"crossref","award":["UL1 RR024150"],"award-info":[{"award-number":["UL1 RR024150"]}],"id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Michael Gordon Charitable Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.amjcard.2015.11.016","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T03:00:23Z","timestamp":1447902023000},"page":"436-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Usefulness of Von Willebrand Factor Activity Indexes to\u00a0Predict Therapeutic Response in Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"117","clinical-trial-number":[{"clinical-trial-number":"nct01334801","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Joseph L.","family":"Blackshear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Safford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Wysokinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oral A.","family":"Waldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian P.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Ung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Landolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.11.016_bib1","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.jacc.2011.10.825","article-title":"2011 ACCF\/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/CIRCRESAHA.116.305046","article-title":"Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions","volume":"116","author":"Van Belle","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2015.11.016_bib3","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","article-title":"Shear-dependent changes in the three-dimensional structure of human von Willebrand factor","volume":"88","author":"Siedlecki","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.amjcard.2015.11.016_bib4","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/CIRCULATIONAHA.108.786681","volume":"118","author":"Le Tourneau","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.11.016_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4065\/mcp.2010.0309","article-title":"Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy","volume":"86","author":"Blackshear","year":"2011","journal-title":"Mayo Clinc Proc"},{"key":"10.1016\/j.amjcard.2015.11.016_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jth.12780","article-title":"Remission of recurrent gastrointestinal bleeding after septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy-associated acquired von Willebrand syndrome","volume":"13","author":"Blackshear","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2015.11.016_bib7","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMcibr1205363","article-title":"From clinical observation to mechanism\u2014Heyde\u2019s syndrome","volume":"367","author":"Loscalzo","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.11.016_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14797\/mdcj-11-1-24","article-title":"Gastrointestinal bleeding after continuous flow left ventricular device implantation: review of pathophysiology and management","volume":"11","author":"Guha","year":"2015","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.amjcard.2015.11.016_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjcard.2012.10.015","article-title":"Indexes of von Willebrand factor as biomarkers of aortic stenosis severity: (From the Biomarkers of Aortic Stenosis Severity {BASS} Study)","volume":"111","author":"Blackshear","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib10","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jacc.2014.02.581","article-title":"B-type natriuretic peptid clinical activation in aortic stenosis: impact on long-term survival","volume":"63","author":"Clavel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib11","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.12734","article-title":"Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation","volume":"12","author":"Blackshear","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2015.11.016_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.11.016_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2015.02.008","article-title":"Loss of high molecular weight multimers of Von Willebrand factor in aortic stenosis with transcatheter aortic valve replacement (TAVR)","volume":"8","author":"Spangenberg","year":"2015","journal-title":"JACC Cardiovasc Interventions"},{"key":"10.1016\/j.amjcard.2015.11.016_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cjca.2015.01.012","article-title":"Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor","volume":"31","author":"Caspar","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.11.016_bib16","first-page":"191","article-title":"Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present, and future","volume":"94","author":"Ommen","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2015.11.016_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jacc.2008.11.069","article-title":"The 50 year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib19","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jcin.2011.02.014","article-title":"Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy","volume":"4","author":"Geske","year":"2011","journal-title":"JACC Cardiovasc Interventions"},{"key":"10.1016\/j.amjcard.2015.11.016_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/clc.20594","article-title":"Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy","volume":"32","author":"Geske","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib22","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/CIRCULATIONAHA.114.011580","article-title":"Surgical septal myectomy versus alcohol septal ablation, assessing the status of the controversy in 2014","volume":"130","author":"Maron","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.11.016_bib23","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.jacc.2013.04.004","article-title":"B-type natriuretic peptide and survival in hypertrophic cardiomyopathy","volume":"61","author":"Geske","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/eurheartj\/ehn538","article-title":"Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis","volume":"30","author":"Cambronero","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2015.11.016_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1742-1241.2009.02184.x","article-title":"Brain natriuretic peptide and the athlete\u2019s heart: a pilot study","volume":"64","author":"Pagourelias","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.amjcard.2015.11.016_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cardfail.2012.04.005","article-title":"Plasma Pro-B-type natriuretic peptide testing as a screening method of hypertrophic cardiomyopathy","volume":"18","author":"Fernandes","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.amjcard.2015.11.016_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bjh.12272","article-title":"Von Willebrand disease-associated angiodysplasia: a few answers, still many questions","volume":"16","author":"Franchini","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ajg.2014.19","article-title":"Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis","volume":"109","author":"Jackson","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0735-1097(89)90596-2","article-title":"Hypertensive hypertrophic cardiomyopathy of hypertrophic cardiomyopathy with hypertension?: a study of 78 patients","volume":"13","author":"Karam","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.11.016_bib30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.79.3.580","article-title":"Hypertrophic cardiomyopathy in the elderly. Distinctions form the young based on cardiac shape","volume":"79","author":"Lever","year":"1989","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915022547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915022547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T05:57:16Z","timestamp":1617170236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915022547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0002914915022547"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.11.016","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of Von Willebrand Factor Activity Indexes to\u00a0Predict Therapeutic Response in Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}